This inventor holds 1 USPTO granted patent. Top assignee: Cetus Corporation. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Kenneth A. Laderman: Innovator in Pharmaceutical Composition
Introduction
Kenneth A. Laderman is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the stability and solubility of proteins.
Latest Patents
Kenneth holds a patent for a pharmaceutical composition for interleukin-2, which is designed for proteins that are not stably soluble. The invention focuses on IL-2 and includes a composition that comprises amino acids, vitamins, polymers, fatty acids, or low molecular weight acids. This innovation aims to improve the therapeutic efficacy of interleukin-2 in medical applications.
Career Highlights
Kenneth has worked with Cetus Corporation, where he has been instrumental in advancing pharmaceutical research and development. His expertise in protein chemistry and formulation has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Kenneth has collaborated with talented professionals, including Nandini Katre and Maninder Singh Hora. These partnerships have fostered innovation and contributed to the success of various projects within the pharmaceutical sector.
Conclusion
Kenneth A. Laderman's work in pharmaceutical compositions exemplifies the impact of innovative thinking in medicine. His contributions continue to influence the development of effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile